Order Article Reprints

Natarajan SK, Danansezhian JC, Thummar V, Mehta P. Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report. Reports. 2023; 6(1):13. https://doi.org/10.3390/reports6010013

Natarajan, Suman Kalyan, Joice Crystal Danansezhian, Vipulkumar Thummar, and Priya Mehta. 2023. "Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report" Reports 6, no. 1: 13. https://doi.org/10.3390/reports6010013

Natarajan, S. K., Danansezhian, J. C., Thummar, V., & Mehta, P. (2023). Favorable Outcome and Safety of Neoadjuvant Trastuzumab Emtansine (T-DM1) in a HER2-Positive Early Breast Cancer Patient with Severe Renal Disease on Hemodialysis Ineligible for Conventional Chemotherapy: A Case Report. Reports, 6(1), 13. https://doi.org/10.3390/reports6010013